Wockhardt is a research-based, multinational pharmaceutical company that supplies generic finished formulations — as well as APIs, complex APIs, and intermediates — to clients worldwide. Headquartered in Mumbai, India, the company operates 12 manufacturing facilities across India, Ireland, the UK, and the UAE, with approvals from major regulatory agencies worldwide. Wockhardt has a large portfolio of validated API products, and they also provide formulation dose development services.